UK-based health chatbot Babylon Health is selling off its operations in Canada to former partner Telus Health in a licensing deal projected to be worth roughly $70 million, Business Insider reports.
The pair previously inked a deal in 2019 to create Babylon by Telus Health, which allowed users to describe their symptoms to a text-based bot, consult with a provider via video, and store medical...
Babylon’s triage chatbot and virtual confirmation platform has come to Canada’s British Columbia in the form of a newly launch telehealth app, Babylon by Telus Health. The tool allows users to describe their symptoms to the text-based bot, video consult with a licensed practitioner, and store and easily access consultation notes or other information.
The app is the result of a partnership...
The Cadillac of gene tests? 23andMe is considering a $749 premium gene test offering, considerably more expensive than the $99 to $199 products the company has offered thus far, CNBC reports. Some users received email notifications about a premium service at that price, but clicking the link did nothing. According to 23andMe, it’s only testing user interest and has no plans for a roll out.
In...
They may want it, but, for one reason or another, they aren’t using it. While nearly 90 percent of Canadians said in a recent survey that they want digital health technologies – believing it leads to better healthcare – only a small percentage are actually taking advantage of tools, according to a recent survey of over a thousand Canadians.
The survey of 1,009 adults, which was conducted by...
PatientSafe Solutions, maker of mobile hospital workflow system PatientTouch, has secured a $3 million strategic investment and resale agreement from Telus Health, the healthcare arm of Canadian mobile operator Telus.
“This investment and exclusive reseller agreement is the latest validation of PatientSafe’s approach to supporting the future of healthcare on a global scale,” Joseph Condurso,...
Telus health in Canda: Cisco Canada: "In the space of one year, many health-care executives have gone from being unsure about wireless as a primarily delivery mode for network access to clinical and administrative applications to being convinced it's the route to go." Calgary Herald
Lactic acid monitoring: Echo Therapeutics, which has developed a wireless, non-invasive transdermal continuous...
